Home › Forums › AWSIM Member Forum › CMAJ “Managing Ob*sity in Children” – join me in submitting a “Response?”

Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
    Posts
  • #1400
    Sara Sandwith

      Hi AWSIM colleagues,

      Those in Canada may have read the CMAJ’s foray into pediatric weight management guidelines, which feels like “AAP-lite”…

      https://www.cmaj.ca/content/197/14/E372

      I’m interested in what others have to say. I was struck by the committee’s comfort making recommendations based on what they acknowledge is generally low-quality evidence, plus all the usual ‘talking out both sides of the mouth” about somehow avoiding stigma while still doing all the same stigmatizing, evidence-free things.

      There is an option to “respond” to the article. I am reflecting on how to say what I want, and would invite others to add their two bits.

      All the best,

      Sara

      #1407
      Flo Sheppard

        Hi Sara:

        I work in Population and Public Health in northern BC. While the guidelines are focused on management of “O” in children (versus prevention – not of “O” though, health promotion or health equity which are areas I focus) they do have the potential to impact my work.  There have been an initial email conversation in BC (AWSIM members Katarina Wind and Nicole Spencer) about whether there is an opportunity to “respond”. TBD.

        I agree that these guidelines, by pathologizing body size, will not reduce stigma (they note that they are only focused on medical stigma) for people in larger bodies.

        It is troubling that so little “evidence” was used to make statements that pharmacological and surgical interventions should be considered (which has been interpreted by the media as should be offered). As a dietitian, I worry about the impact of offering interventions to children that may impact height, bone density, reproductive health, and so much more in the future. A colleague who works in a short term pediatric weight intervention program in BC (that does not offer pharmacological or surgical interventions) noted that a consultant endo shared that most parents/caregivers, when provided with the risks/benefits of pharmacological interventions, make an informed “no” decision.

        The guidelines lack specificity – i.e. what should a provider consider when suggesting pharmacological and/or surgical interventions to a family? I’ve heard from clinical colleagues that they have patients referred to them who feel bullied by their physician to try GLP 1s.

        I did appreciate that this radio segment was a bit more balanced (while still being steeped in an “O” as disease paradigm): https://www.cbc.ca/listen/live-radio/1-63-the-current/clip/16141006-childhood-obesity-guidelines-absurdity-english-spelling-leaders-fared?onboarding=false

        Looking forward to more dialogue.

      Viewing 2 posts - 1 through 2 (of 2 total)
      • You must be logged in to reply to this topic.